|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.6 USD | -3.08% |
|
-23.68% | -1.18% |
| 05-14 | Transcript : Curis, Inc. - Special Call | |
| 05-14 | Curis, Inc. Announces Additional Data from Take Aim Leukemia Study | CI |
Curis, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 10.16 million compared to USD 10.65 million a year ago. Net loss was USD 56.67 million compared to USD 45.44 million a year ago.
Basic loss per share from continuing operations was USD 12.2 compared to USD 10 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.18% | 74.27M | |
| +33.37% | 50.85B | |
| +1.55% | 42.82B | |
| +49.22% | 42.03B | |
| -4.22% | 29.55B | |
| +11.57% | 26.11B | |
| -21.00% | 19.13B | |
| +7.36% | 13.05B | |
| +28.30% | 12.16B | |
| +23.80% | 12.08B |
CURIS, INC. 